SCHEMBL21301196

SCHEMBL21301196

CCC/C=C1\C=CC(Cl)=CN1/C=C(\C)c1cc2ccc(N3C[C@H](C)NC[C@H]3C)cc2oc1=O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21301458 0.64 SLC16A3 (0.35)
SCHEMBL21301310 0.64 SLC16A3 (0.38)
SCHEMBL15065876 0.64 MIF (0.53)
SCHEMBL15069282 0.62 RAB9A (0.40)
SCHEMBL15086146 0.62 WEE1 (0.32)
SCHEMBL16669851 0.62 KDM4E (0.53)
SCHEMBL21301331 0.60 SLC16A3 (0.38)
SCHEMBL15069029 0.58 ALDH1A1 (0.59)
SCHEMBL5178255 0.58 BCL2A1 (0.45)
SCHEMBL4938713 0.58 BCL2A1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797592-B1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY PTC THERAPEUTICS INC (US) 2019-08-28 EP disclosed